Oprelvekin

Trade Name: Topmega

Generic Name: Oprelvekin (Recombinant Human Interleukin 11, rHuIL-11)

Brief Introduction:

1. National Medical Insurance, Category B.

2. Launched in 2005.

3. National standard bulk supplier of rHuIL-11.

4. Participated in the development and collaborative calibration of rHuIL-11 national reference standards.

Indications:

Severe thrombocytopenia with degree III and IV induced by chemotherapy to solid tumor and to non-marrow leukemia.

Strengths:

1mg/vial, 1.5mg/vial, 2mg/vial, 3mg/vial, 5mg/vial

Product description download：Oprelvekin.pdf

Academic progress

PRE：Filgrastim

ALL

NEXT：NONE

Subscribe and keep in touch